He was also past president of the Catalonian Society of Critical Care, and leader of the EUVAP project, the largest study on VAP management developed in Europe, contributing to a large series of papers on severe hospital-acquired pneumonia (HAP/VAP) and conducting outcomes research on pneumonia. As early as 2003, he was co-recipient of the Emmanuel Wolinski Award from the Infectious Diseases Society of America for his outstanding achievement in research on pneumonia. He reported that antibiotic therapy can be optimized in a significant portion of critically ill patients and, based on the PIRO concept, he improved the management of pneumonia.